{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:37:17Z","timestamp":1760708237906},"reference-count":21,"publisher":"Japanese Society of Toxicology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2010]]},"DOI":"10.2131\/jts.35.619","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T06:28:58Z","timestamp":1286173738000},"page":"619-629","source":"Crossref","is-referenced-by-count":6,"title":["Improvement of the embryonic stem cell test endpoint analysis by use of field potential detection"],"prefix":"10.2131","volume":"35","author":[{"given":"Naoteru","family":"Koseki","sequence":"first","affiliation":[{"name":"Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Deguchi","sequence":"additional","affiliation":[{"name":"Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yamada","sequence":"additional","affiliation":[{"name":"Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Funabashi","sequence":"additional","affiliation":[{"name":"Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaki","family":"Seki","sequence":"additional","affiliation":[{"name":"Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Banach, K., Halbach, M.D., Hu, P., Hescheler, J. and Egert, U. (2003): Development of electrical activity in cardiac myocyte aggregates derived from mouse embryonic stem cells. Am. J. Physiol. Heart Cric. Physiol., 284<\/b>, 2114-2123. ","DOI":"10.1152\/ajpheart.01106.2001"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-2333(01)00007-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Brown, N.A. (1987): Teratogenicity testing in vitro<\/i>: status of validation studies. Arch. Toxicol. Suppl., 11<\/b>, 105-114.","DOI":"10.1007\/978-3-642-72558-6_15"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Brown, N.A., Spielmann, H., Bechter, R., Flint, O.P., Freeman, S.J., Jelinek, R.J., Koch, E., Nau, H., Newall, D.R., Palmer, A.K., Renault, J.Y., Repetto, M.F., Vogel, R. and Wiger, R. (1995): Screening chemicals for reproductive toxicity: the current alternatives. Aletern. Lab. Anim., 23<\/b>, 868-882.","DOI":"10.1177\/026119299502300615"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Buesen, R., Genschow, E., Slawik, B., Visan, A., Spielmann, H., Luch, A. and Seiler, A. (2009): Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro<\/i>. Toxicol. Sci., 108<\/b>, 389-400.","DOI":"10.1093\/toxsci\/kfp012"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Genschow, E., Spielmann, H., Scholz, G., Pohl, I., Seiler, A., Clemann, N., Bremer, S. and Becker, K. (2004): Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro<\/i> embryotoxicity tests. Aletern. Lab. Anim., 32<\/b>, 209-244.","DOI":"10.1177\/026119290403200305"},{"key":"7","unstructured":"Jaffee, O.C. and Jaffee, A.L. (1989): The effects of verapamil on the developing cardiovascular system. Anat. Rec., 223<\/b>, 56A."},{"key":"8","doi-asserted-by":"crossref","unstructured":"Kolossov, E., Lu, Z., Drobinskaya, I., Gassanov, N., Duan, Y., Sauer, H., Manzke, O., Bloch, W., Bohlen, H., Hescheler, J. and Fleischmann, B.K. (2005): Identification and characterization of embryonic stem cell-derived pacemaker and atrial cardiomyocytes. FASEB J., 19<\/b>, 577-579.","DOI":"10.1096\/fj.03-1451fje"},{"issue":"2","key":"9","first-page":"124","volume":"47","year":"1997","ISSN":"http:\/\/id.crossref.org\/issn\/0004-4172","issn-type":"print"},{"key":"10","unstructured":"Miyazaki, H., Imamura, S., Koyama, K., Hara, T., Nishikawa, S., Shiramizu, K., Ohguro, Y. and Shimizu, M. (1974): Safety evaluation of oral 5-Fluorouracil (Acute, subacute, chronic toxicity and teratological studies). Kiso to Rinsyou, 8<\/b>, 2603-2640."},{"key":"11","unstructured":"Pellizzer, C., Bremer, S. and Hartung, T. (2005): Developmental toxicity testing from animal towards embryonic stem cells. ALTEX, 22<\/b>, 47-57."},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2008.09.008"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Piersma, A.H., Genschow, E., Verhoef, A., Spanjersberg, M.Q., Brown, N.A., Brady, M., Burns, A., Clemann, N., Seiler, A. and Spielmann, H. (2004): Validation of the postimplantation rat whole-embryo culture test in the international ECVAM validation study on three in vitro<\/i> embryotoxicity tests. Aletern. Lab. Anim., 32<\/b>, 275-307.","DOI":"10.1177\/026119290403200307"},{"key":"14","unstructured":"Pfizer (2005): Buffered PFIZERPEN (penicillin G potassium) for Injection. U.S. Physician Prescribing Information."},{"key":"15","doi-asserted-by":"crossref","unstructured":"Reppel, M., Pillekamp, F., Brockmeier, K., Matzkies, M., Bekcioglu, A., Lipke, T., Nguemo, F., Bonnemeier, H. and Hescheler, J. (2005): The electrocardiogram of human embryonic stem cell-derived cardiomyocytes. J. Electrocardiol., 38<\/b>, 166-170. ","DOI":"10.1016\/j.jelectrocard.2005.06.029"},{"key":"16","unstructured":"Sanofi-Aventis (2007): RIFAMATE (rifampin and isoniazid capsules USP). Prescribing Information."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Satin, J., Kehat, I., Caspi, O., Huber, I., Arbel, G., Itzhaki, I., Magyar, J., Schroder, E.A., Perlman, I. and Gepstein, L. (2004): Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J. Physiol., 559<\/b>, 479-496.","DOI":"10.1113\/jphysiol.2004.068213"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-2333(99)00046-6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Seiler, A., Visan, A., Buesen, R., Genschow, E. and Spielmann, H. (2004): Improvement of an in vitro<\/i> stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod. Toxicol., 18<\/b>, 231-240.","DOI":"10.1016\/j.reprotox.2003.10.015"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Spielmann, H., Genschow, E., Brown, N.A., Piersma, A.H., Verhoef, A., Spanjersberg, M.Q., Huuskonen, H., Paillard, F. and Seiler, A. (2004): Validation of the rat limb bud micromass test in the international ECVAM validation study on three in vitro<\/i> embryotoxicity tests. Aletern. Lab. Anim., 32<\/b>, 245-274.","DOI":"10.1177\/026119290403200306"},{"key":"21","unstructured":"Sucheston, M.E., Hayes, T.G., Paulson, R.B.  and King, J.E. (1979): Fetal Malformations in Valproate Sodium Treated CD-I Mice. Teratology, 19<\/b>, 49A."}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jts\/35\/5\/35_5_619\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T01:02:29Z","timestamp":1636592549000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jts\/35\/5\/35_5_619\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.35.619","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}